Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China.
Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Virchows Arch. 2019 Feb;474(2):219-226. doi: 10.1007/s00428-018-2498-7. Epub 2018 Nov 28.
To describe the clinicopathological features of nine patients with acute Epstein-Barr virus (EBV)-positive cytotoxic T cell lymphoid hyperplasia (EBV+TLH) in the upper aerodigestive tract, in which initial findings led to a preliminary misdiagnosis of extranodal NK/T cell lymphoma, nasal type (ENKTL). A series of nine cases of EBV+TLH in one Chinese institution over a 9-year interval was retrospectively analyzed. Median age was 16 years (range 5-29 years) with a M:F ratio of 5:4. All patients were previously healthy with an acute onset period of < 1 month. Six patients (66%) presented with masses or polypoid protrusions in the upper aerodigestive tract. Nasopharyngeal symptoms, cervical lymphadenopathy, and fever were found in 89%, 78%, and 56% of patients, respectively. In seven cases, morphology mainly showed small-sized irregular cells and in two cases medium-to-large cells. In all cases, the cells diffusely expressed cytoplasmic CD3 and at least one marker for cytotoxic granules, but were negative for CD56. CD5 expression was detected in eight cases (8/9, 89%). In all cases, double staining for CD3 and EBER indicated that most T cells were infected with EBV. T cell receptor gene rearrangement was performed in five cases and all showed polyclonal results. All patients achieved complete remission within 1 month after diagnosis without any chemoradiotherapy and were followed up 19-124 months without recurrent disease. EBV+TLH in the upper aerodigestive tract is occasionally observed in China. The histopathologic features of EBV+TLH can mimic ENKTL. EBV+TLH should be taken into consideration as a potential diagnosis when the disease duration is short, spontaneous remission is achieved without intervention, and when histology shows infiltration with EBV-infected T lymphocytes.
为了描述 9 例发生在上呼吸道的急性 EBV 阳性细胞毒性 T 细胞淋巴组织增生症(EBV+TLH)患者的临床病理特征,这些患者最初的检查结果导致了初步误诊为结外 NK/T 细胞淋巴瘤,鼻型(ENKTL)。回顾性分析了 9 例在 9 年期间发生于同一中国机构的 EBV+TLH 患者的临床资料。中位年龄为 16 岁(范围 5-29 岁),男女比例为 5:4。所有患者均为既往健康,急性发病期<1 个月。6 例(66%)患者以上呼吸道肿块或息肉样突起为首发症状。89%、78%和 56%的患者分别出现鼻咽部症状、颈部淋巴结肿大和发热。7 例形态学主要表现为小而不规则细胞,2 例为中-大细胞。所有病例均弥漫性表达胞质 CD3 和至少一种细胞毒性颗粒标志物,但 CD56 阴性。8 例(8/9,89%)检测到 CD5 表达。所有病例的 CD3 和 EBER 双重染色均表明大多数 T 细胞感染 EBV。5 例进行了 T 细胞受体基因重排,均表现为多克隆结果。所有患者在诊断后 1 个月内达到完全缓解,无需放化疗,随访 19-124 个月无疾病复发。在中国,偶尔会观察到上呼吸道 EBV+TLH。EBV+TLH 的组织病理学特征可与 ENKTL 相混淆。当疾病持续时间短、无干预即可自发缓解、且组织学表现为 EBV 感染 T 淋巴细胞浸润时,应考虑将 EBV+TLH 作为潜在诊断。